THOMPSON VIRGIL
SEC CIK 1218821 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals, Inc. | Dir | 123.8K | — | — | 5 | 2021-08-05 | 2023-06-27 |
Most active insiders at PCSA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ng George K | CEO, Dir | $55.0K | — |
| 2 | SKIBSTED RUSSELL | CFO | $41.7K | — |
| 3 | Guy Wendy | Chief Administrative Off | $32.9K | — |
| 4 | Young David | Pres. Research, Development, Dir | $32.4K | — |
| 5 | Lin Patrick | Chief Business - Strategy Off | $28.5K | — |
| 6 | Bigora Sian | Chief Development Off | $21.4K | — |
| 7 | Baluch Khoso | Dir | $5,752 | — |
| 8 | Pannu Geraldine | Dir | $5,253 | — |
| 9 | Neal James R | Dir | $2,000 | — |
| 10 | Yorke Justin W | Dir | — | — |
THOMPSON VIRGIL made no open-market trades at PCSA in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-07-24 | 2023-06-27 | PCSA | Processa Pharmaceuticals, Inc. | THOMPSON VIRGIL | Dir | M - OptEx | — | +23.6K | 123.8K | +24% | — |
| DI | 2023-01-04 | 2022-12-31 | PCSA | Processa Pharmaceuticals, Inc. | THOMPSON VIRGIL | Dir | M - OptEx | — | +18.2K | 100.2K | +22% | — |
| 2022-08-09 | 2022-08-05 | PCSA | Processa Pharmaceuticals, Inc. | THOMPSON VIRGIL | Dir | M - OptEx | — | +1,169 | 16.7K | +8% | — | |
| 2022-04-04 | 2022-03-31 | PCSA | Processa Pharmaceuticals, Inc. | THOMPSON VIRGIL | Dir | A - Grant | — | +4,393 | 16.7K | +36% | — | |
| 2021-08-09 | 2021-08-05 | PCSA | Processa Pharmaceuticals, Inc. | THOMPSON VIRGIL | Dir | A - Grant | — | +1,169 | 12.3K | +11% | — |
Purchase Sale Sale after option exercise All abbreviations